101 related articles for article (PubMed ID: 38769694)
1. Enterotoxin-related genes PPFIA4 and SCN3B promote colorectal cancer development and progression.
Zheng FX; Yang CR; Sun FY; Zhang YZ; Wang YL; Li XZ; Wu XY
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23746. PubMed ID: 38769694
[TBL] [Abstract][Full Text] [Related]
2. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
3. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
4. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
5. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
6. Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data.
Liu W; Luo X; Zhang Z; Chen Y; Dai Y; Deng J; Yang C; Liu H
Cancer Immunol Immunother; 2024 Mar; 73(4):69. PubMed ID: 38430268
[TBL] [Abstract][Full Text] [Related]
7. Identification of a five-gene signature with prognostic value in colorectal cancer.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
[TBL] [Abstract][Full Text] [Related]
9. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
Liang Z; Li X
Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
[TBL] [Abstract][Full Text] [Related]
10. Identification and verification of key cancer genes associated with prognosis of colorectal cancer based on bioinformatics analysis.
Qin Y; Chen L; Chen L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 46(10):1063-1070. PubMed ID: 34911835
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics Analysis of Prognosis-Related Genes and Expression of CXCL8 in Colorectal Cancer.
Yao Z; Pan X; Chen W; Pei Y; Chen C; Huang Y; Liu S; Liu Y
Biomed Res Int; 2022; 2022():3149887. PubMed ID: 35845924
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer.
Lu C; Liao W; Huang Y; Huang Y; Luo Y
BMC Gastroenterol; 2022 Apr; 22(1):207. PubMed ID: 35473611
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
14. Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.
Yang X; Wei W; Tan S; Guo L; Qiao S; Yao B; Wang Z
World J Surg Oncol; 2021 Aug; 19(1):248. PubMed ID: 34419055
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients.
Shen KY; Chen BY; Gao WC
Dis Markers; 2022; 2022():8347125. PubMed ID: 35968507
[TBL] [Abstract][Full Text] [Related]
16. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
[TBL] [Abstract][Full Text] [Related]
17. Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment.
Luo Q; Zhou P; Chang S; Huang Z; Zeng X
Sci Rep; 2023 Mar; 13(1):5106. PubMed ID: 36991138
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Significances and Prognostic Value of
Fu F; Niu R; Zheng M; Yang X; Fan L; Fu W; Zhang S
J Cancer; 2023; 14(1):24-34. PubMed ID: 36605492
[No Abstract] [Full Text] [Related]
19. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
20. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
